soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 results Oral Semaglutide in High-Risk Type 2 Diabetes: Cardiovascular Benefit Confirmed in the SOUL Trial Clinical Effectiveness and Safety of – The Role of Glucagon-Like Peptide-1

US$ 25.93

★★★★★ 4.4 (13 reviews)

US$ 20.09

★★★★★ 4.8 (22 reviews)

US$ 28.60

★★★★★ 4.0 (7 reviews)

US$ 21.04

★★★★★ 4.5 (23 reviews)

US$ 29.64

★★★★★ 4.6 (23 reviews)

US$ 24.30

★★★★★ 4.1 (30 reviews)

US$ 25.30

★★★★★ 5.0 (18 reviews)

US$ 27.95

★★★★★ 4.3 (14 reviews)

US$ 29.47

★★★★★ 4.7 (17 reviews)

US$ 21.09

★★★★★ 4.0 (6 reviews)

US$ 26.33

★★★★★ 4.6 (7 reviews)

US$ 29.60

★★★★★ 4.4 (30 reviews)

US$ 20.26

★★★★★ 5.0 (15 reviews)

US$ 24.79

★★★★★ 4.2 (25 reviews)

US$ 25.34

★★★★★ 4.8 (9 reviews)

US$ 20.94

★★★★★ 4.0 (23 reviews)

US$ 21.13

★★★★★ 4.5 (8 reviews)

US$ 20.32

★★★★★ 4.6 (9 reviews)

US$ 25.33

★★★★★ 4.4 (8 reviews)

US$ 28.31

★★★★★ 4.1 (5 reviews)